Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizophrenia Therapeutics”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02717195
What this trial is testing

Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia

Who this might be right for
Schizophrenia
H. Lundbeck A/S 1,098
Large-scale testing (Phase 3)Study completedNCT00140192
What this trial is testing

Creatine Treatment in Psychiatric Disorders

Who this might be right for
Schizophrenia
Beersheva Mental Health Center 12
Not applicableStudy completedNCT02976077
What this trial is testing

RC2S+: Remediation of Social Cognitive Impairments

Who this might be right for
Schizophrenia
Hôpital le Vinatier 50
Not applicableStudy completedNCT02377505
What this trial is testing

Deep Brain Stimulation in Treatment Resistant Schizophrenia

Who this might be right for
Refractory Schizophrenia
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 8
Testing effectiveness (Phase 2)Study completedNCT00594256
What this trial is testing

Sodium Oxybate in Schizophrenia With Insomnia

Who this might be right for
SchizophreniaInsomnia Related to Schizophrenia (307.42)
Nathan Kline Institute for Psychiatric Research 8
Large-scale testing (Phase 3)Looking for participantsNCT03094429
What this trial is testing

An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults

Who this might be right for
Refractory Schizophrenia
SyneuRx International (Taiwan) Corp 287
Large-scale testing (Phase 3)Study completedNCT02013531
What this trial is testing

Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms

Who this might be right for
Major Depressive DisorderAnxiety
Otsuka Pharmaceutical Development & Commercialization, Inc. 37
Large-scale testing (Phase 3)Study completedNCT05838625
What this trial is testing

Study of Two Digital Therapeutics for the Treatment of Experiential Negative Symptoms of Schizophrenia

Who this might be right for
Schizophrenia
Click Therapeutics, Inc. 464
Large-scale testing (Phase 3)Study completedNCT02983188
What this trial is testing

Berberine as Adjuvant Treatment for Schizophrenia Patients

Who this might be right for
SchizophreniaSchizophrenia Spectrum and Other Psychotic DisordersMetabolic Syndrome x
The University of Hong Kong 113
Post-approval studies (Phase 4)Study completedNCT00727103
What this trial is testing

Varenicline Treatment in Alcohol and Nicotine Dependent Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderAlcohol Dependence+1 more
State University of New York - Upstate Medical University 10
Post-approval studies (Phase 4)WithdrawnNCT00786318
What this trial is testing

Ziprasidone vs Standard Therapy for Agitated Patients in the ED

Who this might be right for
PsychosisAgitationDelirium
George Washington University
Testing effectiveness (Phase 2)UnknownNCT01045720
What this trial is testing

The Treatment of 2 Chinese Medicines in Clozapine-induced Hypersalivation in Schizophrenia

Who this might be right for
SchizophreniaClozapineHypersalivation+1 more
Taichung Veterans General Hospital 45
Not applicableStudy completedNCT00169988
What this trial is testing

Antidepressant and Antipsychotic to Treat Attenuated Positive and Negative Symptoms

Who this might be right for
Prodromal SchizophreniaPsychotic Disorders
Northwell Health 8
Post-approval studies (Phase 4)Study completedNCT00007774
What this trial is testing

To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia

Who this might be right for
Schizoaffective DisorderSchizophrenia
US Department of Veterans Affairs 600
Not applicableStudy completedNCT03548155
What this trial is testing

Berberine Effects on Clinical Symptoms and Metabolic Disturbance in Patients With Schizophrenia

Who this might be right for
SchizophreniaTherapeutics
Tianjin Anding Hospital 65
Not applicableUnknownNCT03000985
What this trial is testing

Evaluation of a Psychoeducation Program for Families Caregivers of Schizophrenic Patients : Randomized Study in Two Arms

Who this might be right for
SchizophreniaMental DisorderEducational Problems+5 more
Centre Hospitalier Charles Perrens, Bordeaux 60
Post-approval studies (Phase 4)Looking for participantsNCT06969755
What this trial is testing

Biomarkers to Enhance Early Schizophrenia Treatment

Who this might be right for
Schizophenia Disorder
Northwell Health 180
Testing effectiveness (Phase 2)Looking for participantsNCT07185815
What this trial is testing

Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine

Who this might be right for
SchizophreniaBipolar I DisorderMajor Depressive Disorder
Mapi Pharma Ltd. 24
Not applicableStudy completedNCT06199817
What this trial is testing

The Effect Of Multiple Occupational Therapies On Functional Remission And Subjective Recovery For Schizophrenia

Who this might be right for
Occupational TherapySchizophreniaRemission+1 more
Ege University 55
Not applicableStudy completedNCT00283517
What this trial is testing

A Registry of Treatment Adherence for Patients With Schizophrenia

Who this might be right for
SchizophreniaPsychotic Disorders
Janssen-Cilag, S.A. 2,046
Next Page